Boston Scientific Receives FDA Approval, CE Mark for DVT Catheter

Boston Scientific has won FDA approval and CE Mark for its AngioJet ZelanteDVT thrombectomy catheter designed to treat deep vein thrombosis in large-diameter upper and lower limb peripheral veins.

The catheter is built to remove large venous clots and facilitate rapid restoration of blood flow, providing four times the thrombus removal power of existing AngioJet catheters, the company says.

Deep vein thrombosis occurs when a blood clot forms in one or more of the deep veins — frequently in the legs.

The device is designed to break apart and remove these clots from iliofemoral and lower extremity veins greater than or equal to 6.0 mm in diameter. — Michael Cipriano